SENNOSIDES AND DOCUSATE SODIUM

SENNOSIDES AND DOCUSATE SODIUM was reported 2921 times

SENNOSIDES AND DOCUSATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILIRUBIN CONJUGATED ABNORMAL 2 0.0180
1 STOMA SITE ODOUR 3 0.0134
2 CONFUSIONAL AROUSAL 2 0.0124
3 ACUTE RIGHT VENTRICULAR FAILURE 2 0.0118
4 INCISION SITE DISCHARGE 2 0.0079
5 CULTURE WOUND POSITIVE 2 0.0077
6 AMMONIA ABNORMAL 3 0.0074
7 DIABETIC GANGRENE 2 0.0070
8 HEART FAILURE WITH PRESERVED EJECTION FRACTION 2 0.0068
9 DEVICE MAINTENANCE ISSUE 4 0.0068
10 FEEDING TUBE USER 2 0.0055
11 STOMA SITE HYPERGRANULATION 3 0.0048
12 INFUSION SITE DISCHARGE 8 0.0046
13 MITRAL VALVE STENOSIS 3 0.0045
14 ALLERGY TO PLANTS 2 0.0044
15 EHLERS-DANLOS SYNDROME 2 0.0043
16 GENITAL ERYTHEMA 2 0.0040
17 MEDICAL DEVICE SITE DISCOMFORT 3 0.0037
18 INFUSION SITE OEDEMA 3 0.0036
19 ANAEMIA OF CHRONIC DISEASE 3 0.0033
20 CERUMEN IMPACTION 3 0.0033
21 ALCOHOL INTERACTION 6 0.0031
22 HAND DERMATITIS 2 0.0029
23 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
24 STOMA SITE ERYTHEMA 5 0.0027
25 DEVICE DAMAGE 2 0.0025
26 NASAL ULCER 4 0.0025
27 FAILURE TO THRIVE 13 0.0025
28 HYPERPARATHYROIDISM SECONDARY 6 0.0024
29 DENTAL DISCOMFORT 2 0.0024
30 FRACTURED COCCYX 3 0.0024
31 HOSPICE CARE 23 0.0023
32 PROTEIN TOTAL ABNORMAL 3 0.0023
33 FOOD REFUSAL 2 0.0023
34 RHONCHI 3 0.0022
35 CATHETER SITE SWELLING 2 0.0021
36 INFUSION SITE HAEMORRHAGE 7 0.0021
37 INFUSION SITE NODULE 2 0.0021
38 COCCYDYNIA 3 0.0020
39 CANCER PAIN 5 0.0020
40 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
41 INFUSION SITE MASS 2 0.0018
42 DERMATITIS CONTACT 21 0.0018
43 SHOULDER FRACTURE 3 0.0018
44 STOMA SITE DISCHARGE 5 0.0018
45 HYPERVOLAEMIA 9 0.0018
46 DEMENTIA WITH LEWY BODIES 2 0.0018
47 KLEBSIELLA SEPSIS 2 0.0018
48 BLOOD LOSS ANAEMIA 4 0.0018
49 NEPHROGENIC ANAEMIA 8 0.0017
50 BLADDER OPERATION 2 0.0017
51 HYPORESPONSIVE TO STIMULI 2 0.0017
52 INCISION SITE PAIN 2 0.0017
53 GLOSSITIS 6 0.0017
54 CHRONIC RESPIRATORY FAILURE 2 0.0017
55 DEVICE ALARM ISSUE 3 0.0017
56 ESSENTIAL HYPERTENSION 3 0.0016
57 BLADDER PROLAPSE 2 0.0016
58 DIASTOLIC DYSFUNCTION 5 0.0016
59 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
60 LIVING IN RESIDENTIAL INSTITUTION 3 0.0016
61 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
62 CATHETER SITE HAEMORRHAGE 4 0.0016
63 PROTEIN TOTAL DECREASED 6 0.0016
64 BLOOD BILIRUBIN ABNORMAL 2 0.0016
65 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
66 NASAL SEPTUM DEVIATION 3 0.0015
67 MULTIPLE ALLERGIES 12 0.0015
68 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
69 GASTRITIS EROSIVE 7 0.0015
70 CARBOHYDRATE ANTIGEN 125 INCREASED 5 0.0015
71 CLUSTER HEADACHE 2 0.0015
72 INFUSION SITE RASH 2 0.0015
73 RENAL MASS 3 0.0015
74 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
75 NEUROGENIC BLADDER 3 0.0014
76 GENITAL RASH 2 0.0014
77 INFUSION SITE BRUISING 3 0.0014
78 THORACIC VERTEBRAL FRACTURE 4 0.0014
79 HAEMATOCRIT INCREASED 3 0.0013
80 INFUSION SITE ERYTHEMA 11 0.0013
81 EYE ALLERGY 2 0.0013
82 REHABILITATION THERAPY 5 0.0013
83 PRURITUS GENITAL 3 0.0013
84 VOLVULUS 3 0.0013
85 KERATOPATHY 2 0.0013
86 OXYGEN CONSUMPTION INCREASED 3 0.0013
87 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
88 PLASMA CELL MYELOMA RECURRENT 4 0.0012
89 POSTURE ABNORMAL 4 0.0012
90 DEVICE INFUSION ISSUE 3 0.0012
91 PLATELET DISORDER 3 0.0012
92 EXCORIATION 3 0.0012
93 APPENDICITIS PERFORATED 3 0.0012
94 ARTERIOSCLEROSIS 11 0.0012
95 AMYLOIDOSIS 2 0.0012
96 ACUTE SINUSITIS 2 0.0012
97 PLATELET COUNT ABNORMAL 7 0.0012
98 TASTE DISORDER 23 0.0011
99 GASTROINTESTINAL STROMAL TUMOUR 3 0.0011
100 JUGULAR VEIN THROMBOSIS 2 0.0011
101 INFUSION SITE SWELLING 7 0.0011
102 DECUBITUS ULCER 9 0.0011
103 INFUSION SITE PAIN 14 0.0011
104 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
105 SKIN ABRASION 5 0.0011
106 WEIGHT FLUCTUATION 11 0.0011
107 BLOOD MAGNESIUM DECREASED 9 0.0010
108 ADRENAL DISORDER 2 0.0010
109 PARAPLEGIA 3 0.0010
110 FAECES HARD 4 0.0010
111 DEVICE POWER SOURCE ISSUE 3 0.0010
112 ONYCHOCLASIS 7 0.0010
113 DROOLING 7 0.0010
114 SKIN LACERATION 11 0.0010
115 DIABETIC NEUROPATHY 5 0.0010
116 EYELID PAIN 2 0.0010
117 RIB FRACTURE 20 0.0010
118 MENTAL STATUS CHANGES 27 0.0010
119 CACHEXIA 5 0.0010
120 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
121 ATRIAL TACHYCARDIA 2 0.0010
122 INFUSION SITE PRURITUS 3 0.0009
123 DEVICE CONNECTION ISSUE 2 0.0009
124 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
125 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
126 INTERVERTEBRAL DISC DISORDER 4 0.0009
127 CATHETER SITE ERYTHEMA 2 0.0009
128 COMPRESSION FRACTURE 5 0.0009
129 BLOOD TESTOSTERONE INCREASED 2 0.0009
130 BACTERIAL SEPSIS 3 0.0009
131 COLONOSCOPY 2 0.0009
132 CLOSTRIDIUM TEST POSITIVE 2 0.0009
133 PELVIC FRACTURE 7 0.0009
134 PLASMA CELL MYELOMA 35 0.0009
135 WOUND DEHISCENCE 3 0.0009
136 GASTRIC POLYPS 2 0.0009
137 CERVICAL VERTEBRAL FRACTURE 3 0.0009
138 FLAT AFFECT 2 0.0009
139 ARTHRITIS INFECTIVE 4 0.0009
140 INFUSION SITE INFECTION 2 0.0009
141 BLOOD COUNT ABNORMAL 13 0.0009
142 TIBIA FRACTURE 4 0.0009
143 INCONTINENCE 9 0.0009
144 TUMOUR MARKER INCREASED 4 0.0008
145 HAEMATOLOGICAL INFECTION 2 0.0008
146 DERMAL CYST 2 0.0008
147 DENTAL OPERATION 2 0.0008
148 STAPHYLOCOCCAL SEPSIS 4 0.0008
149 INFREQUENT BOWEL MOVEMENTS 2 0.0008
150 PRE-EXISTING CONDITION IMPROVED 5 0.0008
151 BLOOD SODIUM DECREASED 15 0.0008
152 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
153 CLAVICLE FRACTURE 3 0.0008
154 NEUTROPHIL COUNT INCREASED 8 0.0008
155 OESOPHAGEAL DISORDER 3 0.0008
156 CATHETER SITE PAIN 2 0.0008
157 KIDNEY INFECTION 15 0.0008
158 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
159 EXFOLIATIVE RASH 2 0.0008
160 CONSTIPATION 165 0.0008
161 BODY HEIGHT DECREASED 8 0.0007
162 BLOOD SODIUM INCREASED 2 0.0007
163 FEEDING DISORDER 15 0.0007
164 PULMONARY THROMBOSIS 8 0.0007
165 BLOOD PHOSPHORUS INCREASED 2 0.0007
166 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
167 SPINAL COMPRESSION FRACTURE 6 0.0007
168 THYROID FUNCTION TEST ABNORMAL 3 0.0007
169 HEART RATE ABNORMAL 4 0.0007
170 ANAL HAEMORRHAGE 2 0.0007
171 ANGIOPATHY 4 0.0007
172 DRUG TOLERANCE DECREASED 2 0.0007
173 MUSCULOSKELETAL CHEST PAIN 11 0.0007
174 EYE INFECTION 8 0.0007
175 SEASONAL ALLERGY 10 0.0007
176 HAND FRACTURE 5 0.0007
177 POOR PERIPHERAL CIRCULATION 3 0.0007
178 LUNG NEOPLASM 3 0.0007
179 BLOOD POTASSIUM DECREASED 21 0.0007
180 NEOPLASM 8 0.0007
181 FULL BLOOD COUNT DECREASED 14 0.0007
182 FIBULA FRACTURE 2 0.0007
183 HORDEOLUM 3 0.0007
184 PYELONEPHRITIS 6 0.0007
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
186 ONYCHOMYCOSIS 3 0.0007
187 URINE ODOUR ABNORMAL 4 0.0007
188 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
189 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
190 INFUSION SITE REACTION 2 0.0007
191 GASTROINTESTINAL INFECTION 6 0.0007
192 ATYPICAL PNEUMONIA 2 0.0007
193 CEREBROVASCULAR DISORDER 2 0.0007
194 CENTRAL VENOUS CATHETERISATION 2 0.0007
195 VASCULAR DEVICE INFECTION 3 0.0007
196 EMERGENCY CARE 2 0.0007
197 UNRESPONSIVE TO STIMULI 17 0.0007
198 HAEMOGLOBIN INCREASED 3 0.0007
199 SINUS DISORDER 13 0.0007
200 DISEASE COMPLICATION 3 0.0007
201 LUMBAR VERTEBRAL FRACTURE 3 0.0007
202 PNEUMONIA BACTERIAL 6 0.0007
203 DIABETIC FOOT 2 0.0007
204 BRAIN NEOPLASM 6 0.0007
205 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
206 RENAL FAILURE CHRONIC 5 0.0006
207 IRON DEFICIENCY ANAEMIA 6 0.0006
208 SMALL INTESTINAL OBSTRUCTION 8 0.0006
209 DECREASED ACTIVITY 7 0.0006
210 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
211 FOOD ALLERGY 5 0.0006
212 PRODUCT DISTRIBUTION ISSUE 6 0.0006
213 ROSACEA 3 0.0006
214 MULTIPLE MYELOMA 3 0.0006
215 YELLOW SKIN 3 0.0006
216 DEVICE OCCLUSION 9 0.0006
217 BREAST CANCER RECURRENT 2 0.0006
218 DRUG EFFECT INCREASED 2 0.0006
219 BLOOD URINE PRESENT 12 0.0006
220 NERVE INJURY 7 0.0006
221 URINARY TRACT INFECTION 107 0.0006
222 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
223 MALNUTRITION 7 0.0006
224 ORAL PAIN 14 0.0006
225 KIDNEY TRANSPLANT REJECTION 3 0.0006
226 ACUTE RESPIRATORY FAILURE 12 0.0006
227 PROCTALGIA 4 0.0006
228 PULMONARY ARTERIAL HYPERTENSION 9 0.0006
229 ATELECTASIS 6 0.0006
230 HERNIA 12 0.0006
231 DIZZINESS POSTURAL 6 0.0006
232 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
233 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
234 MICTURITION URGENCY 7 0.0006
235 STOMATITIS 37 0.0006
236 HAEMATOCRIT DECREASED 12 0.0006
237 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
238 DEHYDRATION 80 0.0006
239 FLUID INTAKE REDUCED 3 0.0006
240 MENINGITIS 4 0.0006
241 ECONOMIC PROBLEM 9 0.0006
242 BRONCHIECTASIS 4 0.0006
243 POSTOPERATIVE WOUND INFECTION 4 0.0006
244 INSURANCE ISSUE 9 0.0006
245 AMMONIA INCREASED 3 0.0006
246 PSEUDOMONAS INFECTION 5 0.0006
247 POOR VENOUS ACCESS 6 0.0006
248 LYMPHOEDEMA 4 0.0006
249 LABORATORY TEST ABNORMAL 17 0.0006
250 LOWER LIMB FRACTURE 11 0.0006
251 MASS 8 0.0006
252 EAR PRURITUS 2 0.0006
253 BLOOD CALCIUM INCREASED 5 0.0006
254 BLOOD LACTIC ACID INCREASED 3 0.0006
255 NEUROPATHY PERIPHERAL 54 0.0006
256 FULL BLOOD COUNT ABNORMAL 6 0.0006
257 CYSTITIS 18 0.0006
258 ILEUS 7 0.0006
259 PLATELET COUNT DECREASED 60 0.0006
260 RETCHING 12 0.0006
261 RED BLOOD CELL COUNT DECREASED 16 0.0006
262 ANAL INCONTINENCE 5 0.0006
263 FACIAL BONES FRACTURE 2 0.0006
264 BONE LESION 2 0.0006
265 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
266 GASTROENTERITIS VIRAL 10 0.0006
267 FAECES SOFT 4 0.0005
268 DEVICE KINK 2 0.0005
269 DYSSTASIA 16 0.0005
270 GASTROINTESTINAL PAIN 6 0.0005
271 INTESTINAL ISCHAEMIA 3 0.0005
272 HYPERKERATOSIS 3 0.0005
273 SENSITIVE SKIN 4 0.0005
274 SKIN ULCER 14 0.0005
275 ARTHROPOD BITE 4 0.0005
276 CARDIAC DYSFUNCTION 2 0.0005
277 DYSPNOEA EXERTIONAL 20 0.0005
278 HIP FRACTURE 17 0.0005
279 PRODUCTIVE COUGH 25 0.0005
280 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
281 MUSCULOSKELETAL DISCOMFORT 9 0.0005
282 BOWEL MOVEMENT IRREGULARITY 4 0.0005
283 EXERCISE TOLERANCE DECREASED 3 0.0005
284 DECREASED APPETITE 121 0.0005
285 METASTASES TO LUNG 6 0.0005
286 CONCUSSION 4 0.0005
287 SKIN WARM 3 0.0005
288 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
289 THROMBOSIS 41 0.0005
290 KNEE OPERATION 5 0.0005
291 HEAD INJURY 16 0.0005
292 FALL 168 0.0005
293 FURUNCLE 4 0.0005
294 NASAL DISCOMFORT 4 0.0005
295 HALLUCINATION 38 0.0005
296 MYOCLONUS 6 0.0005
297 GOUT 9 0.0005
298 AZOTAEMIA 2 0.0005
299 CONTUSION 48 0.0005
300 GANGRENE 3 0.0005
301 CELLULITIS 25 0.0005
302 FUNGAL SKIN INFECTION 2 0.0005
303 END STAGE RENAL DISEASE 9 0.0005
304 BACK DISORDER 8 0.0005
305 MUSCLE SPASTICITY 6 0.0005
306 ABNORMAL FAECES 4 0.0005
307 HICCUPS 4 0.0005
308 SPINAL OPERATION 6 0.0005
309 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
310 SCOLIOSIS 3 0.0005
311 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
312 SECRETION DISCHARGE 6 0.0005
313 INTESTINAL OBSTRUCTION 18 0.0005
314 HAEMOGLOBIN DECREASED 49 0.0005
315 HALLUCINATIONS, MIXED 2 0.0005
316 CANDIDA INFECTION 8 0.0005
317 JOINT DISLOCATION 5 0.0005
318 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
319 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
320 HYPOPHAGIA 12 0.0005
321 ABSCESS LIMB 2 0.0005
322 ENTERITIS 3 0.0005
323 HAEMORRHAGE INTRACRANIAL 7 0.0005
324 VITAMIN D DECREASED 4 0.0005
325 HEREDITARY ANGIOEDEMA 5 0.0005
326 BREAST CANCER METASTATIC 5 0.0005
327 WOUND 13 0.0005
328 CARDIAC FLUTTER 3 0.0005
329 HIATUS HERNIA 6 0.0005
330 CARDIAC MURMUR 4 0.0005
331 BONE CANCER 2 0.0005
332 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
333 BEDRIDDEN 6 0.0005
334 LUNG INFILTRATION 4 0.0005
335 APPETITE DISORDER 3 0.0005
336 BLOOD CREATINE INCREASED 2 0.0005
337 FACIAL PAIN 4 0.0004
338 IMPLANT SITE PAIN 2 0.0004
339 PRODUCT USE COMPLAINT 7 0.0004
340 EYE PAIN 25 0.0004
341 OROPHARYNGEAL DISCOMFORT 4 0.0004
342 PERIPHERAL SWELLING 68 0.0004
343 BODY TEMPERATURE INCREASED 9 0.0004
344 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
345 ABNORMAL LOSS OF WEIGHT 3 0.0004
346 ABDOMINAL HERNIA 2 0.0004
347 SCAB 5 0.0004
348 ECCHYMOSIS 3 0.0004
349 UROSEPSIS 4 0.0004
350 LARGE INTESTINE POLYP 3 0.0004
351 PROCEDURAL PAIN 12 0.0004
352 FLUID RETENTION 22 0.0004
353 DYSPHAGIA 41 0.0004
354 ORAL DISCOMFORT 6 0.0004
355 RIGHT VENTRICULAR FAILURE 3 0.0004
356 METASTASES TO BONE 7 0.0004
357 HALLUCINATION, VISUAL 9 0.0004
358 HYPOXIA 15 0.0004
359 DYSARTHRIA 16 0.0004
360 COUGH 119 0.0004
361 COVID-19 PNEUMONIA 5 0.0004
362 THERMAL BURN 3 0.0004
363 FOOT FRACTURE 8 0.0004
364 SPUTUM DISCOLOURED 4 0.0004
365 BLOOD PRESSURE DECREASED 28 0.0004
366 BLOOD IRON DECREASED 5 0.0004
367 ATAXIA 5 0.0004
368 OROPHARYNGEAL PAIN 39 0.0004
369 POST PROCEDURAL COMPLICATION 8 0.0004
370 WEIGHT DECREASED 116 0.0004
371 MYELODYSPLASTIC SYNDROME 6 0.0004
372 HUMERUS FRACTURE 2 0.0004
373 TONGUE DISORDER 3 0.0004
374 EAR PAIN 8 0.0004
375 MAJOR DEPRESSION 3 0.0004
376 VITAMIN D DEFICIENCY 4 0.0004
377 HAEMORRHOIDS 8 0.0004
378 CYTOPENIA 5 0.0004
379 ILLNESS 42 0.0004
380 THERAPY INTERRUPTED 29 0.0004
381 HYPERCALCAEMIA 5 0.0004
382 LIGAMENT SPRAIN 4 0.0004
383 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
384 CYST 5 0.0004
385 ABDOMINAL TENDERNESS 2 0.0004
386 BLOOD PRESSURE ABNORMAL 8 0.0004
387 GLOSSODYNIA 9 0.0004
388 PRESCRIBED UNDERDOSE 8 0.0004
389 AGEUSIA 10 0.0004
390 HYDRONEPHROSIS 3 0.0004
391 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
392 DEEP VEIN THROMBOSIS 26 0.0004
393 HYPERAMMONAEMIA 2 0.0004
394 CORONARY ARTERY STENOSIS 2 0.0004
395 PRODUCT ADMINISTRATION ERROR 8 0.0004
396 DRY THROAT 4 0.0004
397 DYSPHONIA 23 0.0004
398 SINUSITIS 40 0.0004
399 ENDOCARDITIS 2 0.0004
400 INCREASED UPPER AIRWAY SECRETION 2 0.0004
401 MUSCULAR WEAKNESS 44 0.0004
402 LEUKOCYTOSIS 7 0.0004
403 PNEUMONIA 125 0.0004
404 HAEMATOMA 10 0.0004
405 THERAPY PARTIAL RESPONDER 6 0.0004
406 PULMONARY HYPERTENSION 8 0.0004
407 TENDERNESS 4 0.0004
408 HYPERSOMNIA 11 0.0004
409 PETECHIAE 4 0.0004
410 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
411 TRANSFUSION 4 0.0004
412 ANHEDONIA 10 0.0004
413 ASTHENIA 143 0.0004
414 PLEURAL EFFUSION 23 0.0004
415 RENAL CYST 3 0.0004
416 CONFUSIONAL STATE 61 0.0004
417 OEDEMA PERIPHERAL 46 0.0004
418 RENAL PAIN 4 0.0004
419 GINGIVAL PAIN 3 0.0004
420 BLOOD PRESSURE FLUCTUATION 9 0.0004
421 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
422 FOOD POISONING 2 0.0004
423 QUALITY OF LIFE DECREASED 5 0.0004
424 ACUTE KIDNEY INJURY 57 0.0004
425 PHOTOPHOBIA 7 0.0004
426 FATIGUE 289 0.0004
427 GINGIVITIS 2 0.0004
428 BACK PAIN 86 0.0004
429 BEHAVIOUR DISORDER 2 0.0004
430 CHEILITIS 2 0.0004
431 PHARYNGITIS STREPTOCOCCAL 4 0.0004
432 POST PROCEDURAL INFECTION 3 0.0004
433 OEDEMA 20 0.0004
434 HYPOKALAEMIA 17 0.0004
435 MUSCULOSKELETAL DISORDER 7 0.0004
436 LETHARGY 21 0.0004
437 ABDOMINAL DISTENSION 38 0.0004
438 GASTRIC ULCER HAEMORRHAGE 2 0.0004
439 PNEUMONIA ASPIRATION 9 0.0004
440 FUNGAL INFECTION 12 0.0004
441 SKIN DISORDER 12 0.0004
442 POLLAKIURIA 15 0.0004
443 HYPOMAGNESAEMIA 5 0.0004
444 DRY MOUTH 29 0.0004
445 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
446 FISTULA 4 0.0004
447 MITRAL VALVE INCOMPETENCE 4 0.0004
448 DISORIENTATION 14 0.0004
449 BLOOD CREATININE INCREASED 23 0.0004
450 GRANULOCYTOPENIA 2 0.0004
451 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
452 EPISTAXIS 26 0.0003
453 DELIRIUM 12 0.0003
454 RESPIRATORY TRACT INFECTION 9 0.0003
455 HYPERVENTILATION 2 0.0003
456 DEVICE DISLOCATION 15 0.0003
457 MUCOSAL INFLAMMATION 9 0.0003
458 RASH MACULAR 12 0.0003
459 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
460 HYPOVOLAEMIA 2 0.0003
461 GROIN PAIN 3 0.0003
462 SPINAL OSTEOARTHRITIS 3 0.0003
463 METASTASES TO LIVER 6 0.0003
464 TUMOUR LYSIS SYNDROME 3 0.0003
465 ASCITES 10 0.0003
466 BLOOD PRESSURE INCREASED 52 0.0003
467 LYMPHOCYTE COUNT DECREASED 6 0.0003
468 BRADYKINESIA 2 0.0003
469 HOSPITALISATION 52 0.0003
470 EAR INFECTION 9 0.0003
471 CATARACT 20 0.0003
472 GASTROINTESTINAL HAEMORRHAGE 28 0.0003
473 PULMONARY OEDEMA 15 0.0003
474 THERAPY NON-RESPONDER 15 0.0003
475 RASH PRURITIC 18 0.0003
476 SEPSIS 37 0.0003
477 LIMB INJURY 9 0.0003
478 RESTLESS LEGS SYNDROME 6 0.0003
479 ADRENAL INSUFFICIENCY 4 0.0003
480 OSTEOPENIA 5 0.0003
481 GAIT INABILITY 11 0.0003
482 PRESYNCOPE 8 0.0003
483 NO THERAPEUTIC RESPONSE 4 0.0003
484 LUNG DISORDER 16 0.0003
485 ENCEPHALOPATHY 8 0.0003
486 ABDOMINAL PAIN UPPER 67 0.0003
487 POOR QUALITY SLEEP 7 0.0003
488 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
489 SPEECH DISORDER 17 0.0003
490 CARDIAC FAILURE CONGESTIVE 26 0.0003
491 DYSPNOEA 183 0.0003
492 ANKLE FRACTURE 5 0.0003
493 INFLUENZA 36 0.0003
494 HAEMOPTYSIS 9 0.0003
495 PHARYNGITIS 4 0.0003
496 MENTAL DISORDER 14 0.0003
497 BACTERIAL INFECTION 6 0.0003
498 INFUSION SITE EXTRAVASATION 2 0.0003
499 HAEMATURIA 11 0.0003
500 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
501 OXYGEN SATURATION DECREASED 18 0.0003
502 FLANK PAIN 3 0.0003
503 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
504 FLATULENCE 18 0.0003
505 SICKLE CELL ANAEMIA WITH CRISIS 5 0.0003
506 MUSCLE SPASMS 58 0.0003
507 CHRONIC KIDNEY DISEASE 24 0.0003
508 PNEUMOTHORAX 5 0.0003
509 RESPIRATORY TRACT CONGESTION 5 0.0003
510 ANAEMIA 60 0.0003
511 SLEEP APNOEA SYNDROME 6 0.0003
512 THROAT IRRITATION 14 0.0003
513 INFECTION 45 0.0003
514 BRONCHITIS 23 0.0003
515 SINUS BRADYCARDIA 3 0.0003
516 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
517 HEART RATE IRREGULAR 7 0.0003
518 ATRIAL FIBRILLATION 30 0.0003
519 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
520 PHARYNGEAL SWELLING 3 0.0003
521 NASAL CONGESTION 18 0.0003
522 MOBILITY DECREASED 22 0.0003
523 PULMONARY EMBOLISM 29 0.0003
524 EYE DISORDER 10 0.0003
525 HYPOTENSION 61 0.0003
526 URINARY INCONTINENCE 9 0.0003
527 ORAL CANDIDIASIS 4 0.0003
528 CORONAVIRUS INFECTION 2 0.0003
529 UPPER LIMB FRACTURE 6 0.0003
530 RESPIRATORY DISORDER 9 0.0003
531 CARDIAC FAILURE ACUTE 2 0.0003
532 OVARIAN CYST 3 0.0003
533 COAGULOPATHY 5 0.0003
534 PRODUCT DOSE OMISSION ISSUE 88 0.0003
535 CHOLECYSTITIS CHRONIC 2 0.0003
536 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
537 HYPOTHERMIA 3 0.0003
538 DISEASE PROGRESSION 35 0.0003
539 MOTOR DYSFUNCTION 3 0.0003
540 PALLOR 8 0.0003
541 EUPHORIC MOOD 3 0.0003
542 INITIAL INSOMNIA 3 0.0003
543 EYE MOVEMENT DISORDER 2 0.0003
544 OSTEOPOROSIS 12 0.0003
545 PERIPHERAL COLDNESS 4 0.0003
546 NAUSEA 230 0.0003
547 BONE PAIN 17 0.0003
548 JOINT EFFUSION 2 0.0003
549 LOCALISED INFECTION 7 0.0003
550 HYPERTRANSAMINASAEMIA 2 0.0003
551 ORTHOSTATIC HYPOTENSION 5 0.0003
552 FEBRILE NEUTROPENIA 19 0.0003
553 DEMENTIA 8 0.0003
554 KNEE ARTHROPLASTY 6 0.0003
555 SKIN REACTION 4 0.0003
556 MEMORY IMPAIRMENT 39 0.0003
557 COLD SWEAT 5 0.0003
558 NEPHROLITHIASIS 13 0.0003
559 JOINT INJURY 6 0.0003
560 RENAL DISORDER 13 0.0003
561 BALANCE DISORDER 24 0.0003
562 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
563 GAIT DISTURBANCE 53 0.0003
564 ABDOMINAL PAIN LOWER 7 0.0003
565 BACK INJURY 3 0.0003
566 PRODUCT DOSE OMISSION 18 0.0003
567 IMPAIRED HEALING 9 0.0003
568 WOUND INFECTION 3 0.0003
569 ASPIRATION 3 0.0003
570 STAPHYLOCOCCAL INFECTION 9 0.0003
571 VOMITING 128 0.0003
572 RASH ERYTHEMATOUS 13 0.0003
573 NASOPHARYNGITIS 50 0.0003
574 DIARRHOEA 175 0.0003
575 SKIN HAEMORRHAGE 4 0.0003
576 TOOTH DISORDER 6 0.0003
577 FEELING DRUNK 2 0.0003
578 DUODENAL ULCER PERFORATION 2 0.0003
579 GASTROINTESTINAL DISORDER 24 0.0003
580 COVID-19 47 0.0003
581 SNEEZING 6 0.0003
582 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
583 GENERAL SYMPTOM 2 0.0003
584 BLOOD CALCIUM DECREASED 3 0.0003
585 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
586 COLITIS 10 0.0003
587 INTERNAL HAEMORRHAGE 3 0.0003
588 INCREASED APPETITE 5 0.0003
589 HIP ARTHROPLASTY 4 0.0003
590 MUSCLE TWITCHING 6 0.0003
591 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
592 NEOPLASM PROGRESSION 9 0.0003
593 ELECTROLYTE IMBALANCE 3 0.0003
594 POST PROCEDURAL HAEMORRHAGE 3 0.0003
595 DELUSION 4 0.0003
596 EJECTION FRACTION DECREASED 4 0.0003
597 ACUTE MYELOID LEUKAEMIA 4 0.0003
598 ABDOMINAL DISCOMFORT 43 0.0003
599 BRAIN FOG 4 0.0003
600 DEATH 219 0.0003
601 THERAPY CESSATION 13 0.0003
602 BACTERAEMIA 3 0.0003
603 DIVERTICULITIS 7 0.0003
604 CHOLECYSTITIS 3 0.0003
605 HALLUCINATION, AUDITORY 4 0.0003
606 ACCIDENT 3 0.0003
607 PAIN IN EXTREMITY 74 0.0003
608 SEIZURE 29 0.0003
609 SCIATICA 4 0.0003
610 MUSCLE RIGIDITY 3 0.0003
611 NECK PAIN 14 0.0003
612 WRIST FRACTURE 3 0.0003
613 WEIGHT INCREASED 56 0.0002
614 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
615 SPINAL FRACTURE 5 0.0002
616 HYPERHIDROSIS 32 0.0002
617 MUSCULOSKELETAL PAIN 13 0.0002
618 HYPERGLYCAEMIA 9 0.0002
619 RESPIRATORY FAILURE 18 0.0002
620 FIBROMYALGIA 6 0.0002
621 BLOOD POTASSIUM INCREASED 4 0.0002
622 NEUTROPHIL COUNT DECREASED 10 0.0002
623 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
624 DYSURIA 9 0.0002
625 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
626 CARDIOMEGALY 3 0.0002
627 HYPERAESTHESIA 2 0.0002
628 ESCHERICHIA INFECTION 2 0.0002
629 ABNORMAL WEIGHT GAIN 3 0.0002
630 NEUTROPENIA 33 0.0002
631 ANXIETY 69 0.0002
632 EYE SWELLING 9 0.0002
633 TOOTH EXTRACTION 3 0.0002
634 DRY EYE 12 0.0002
635 PAIN 147 0.0002
636 BLOOD UREA INCREASED 4 0.0002
637 CHILLS 28 0.0002
638 ATRIAL SEPTAL DEFECT 2 0.0002
639 ACUTE MYOCARDIAL INFARCTION 7 0.0002
640 OSTEOARTHRITIS 10 0.0002
641 INADEQUATE ANALGESIA 2 0.0002
642 CARDIAC DISORDER 22 0.0002
643 EATING DISORDER 5 0.0002
644 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
645 CHEST DISCOMFORT 24 0.0002
646 ROTATOR CUFF SYNDROME 3 0.0002
647 IRRITABLE BOWEL SYNDROME 5 0.0002
648 ANOREXIA 3 0.0002
649 INSOMNIA 62 0.0002
650 RECTAL HAEMORRHAGE 10 0.0002
651 PANCYTOPENIA 13 0.0002
652 ABDOMINAL PAIN 54 0.0002
653 FAECES DISCOLOURED 5 0.0002
654 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
655 GASTRITIS 6 0.0002
656 IMMUNE SYSTEM DISORDER 3 0.0002
657 TOOTH INFECTION 3 0.0002
658 MELAENA 5 0.0002
659 SARS-COV-2 TEST POSITIVE 3 0.0002
660 LIMB DISCOMFORT 7 0.0002
661 HEAD DISCOMFORT 4 0.0002
662 HAIR TEXTURE ABNORMAL 3 0.0002
663 THIRST 4 0.0002
664 CEREBRAL HAEMORRHAGE 8 0.0002
665 HAEMOLYTIC ANAEMIA 2 0.0002
666 TREMOR 37 0.0002
667 RASH 97 0.0002
668 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
669 SINUS CONGESTION 3 0.0002
670 FEELING ABNORMAL 53 0.0002
671 TACHYPNOEA 3 0.0002
672 PNEUMONITIS 6 0.0002
673 HEADACHE 138 0.0002
674 BONE DISORDER 4 0.0002
675 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
676 APPLICATION SITE RASH 3 0.0002
677 RESPIRATORY DISTRESS 6 0.0002
678 INCREASED TENDENCY TO BRUISE 2 0.0002
679 CARPAL TUNNEL SYNDROME 3 0.0002
680 MIDDLE INSOMNIA 4 0.0002
681 COGNITIVE DISORDER 10 0.0002
682 APPENDICITIS 2 0.0002
683 BLISTER 12 0.0002
684 CHOLELITHIASIS 7 0.0002
685 LACERATION 2 0.0002
686 LYMPHOPENIA 3 0.0002
687 MALAISE 93 0.0002
688 CARDIAC FAILURE 17 0.0002
689 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
690 FRACTURE 4 0.0002
691 RENAL FAILURE 28 0.0002
692 VIRAL INFECTION 7 0.0002
693 BRONCHOSPASM 3 0.0002
694 URINARY RETENTION 7 0.0002
695 EYE INFLAMMATION 2 0.0002
696 SUBDURAL HAEMATOMA 3 0.0002
697 CARDIOGENIC SHOCK 3 0.0002
698 BLOOD GLUCOSE DECREASED 10 0.0002
699 AFFECT LABILITY 2 0.0002
700 HYPERTHYROIDISM 3 0.0002
701 JOINT SWELLING 25 0.0002
702 SEPTIC SHOCK 9 0.0002
703 HYPOKINESIA 3 0.0002
704 LIVER FUNCTION TEST ABNORMAL 6 0.0002
705 FLUID OVERLOAD 3 0.0002
706 ORAL HERPES 4 0.0002
707 HEPATOMEGALY 2 0.0002
708 DYSPEPSIA 20 0.0002
709 LOSS OF CONSCIOUSNESS 26 0.0002
710 ABASIA 5 0.0002
711 DEPRESSION 46 0.0002
712 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
713 DYSGEUSIA 15 0.0002
714 BLADDER DISORDER 2 0.0002
715 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
716 COLON CANCER 3 0.0002
717 HYPOTONIA 2 0.0002
718 AGGRESSION 10 0.0002
719 BONE LOSS 3 0.0002
720 PYREXIA 69 0.0002
721 HOT FLUSH 15 0.0002
722 APHASIA 6 0.0002
723 LACRIMATION INCREASED 6 0.0002
724 HYPERTENSION 42 0.0002
725 EMPHYSEMA 2 0.0002
726 ARTHROPATHY 11 0.0002
727 LYMPHADENOPATHY 7 0.0002
728 DEVICE FAILURE 3 0.0002
729 DRUG INTOLERANCE 19 0.0002
730 FEELING HOT 12 0.0002
731 ARTHRALGIA 81 0.0002
732 THYROID DISORDER 3 0.0002
733 HELICOBACTER INFECTION 2 0.0002
734 CHEST PAIN 36 0.0002
735 LYMPHOMA 3 0.0002
736 HYPOAESTHESIA 29 0.0002
737 RASH GENERALISED 5 0.0002
738 EYE DISCHARGE 2 0.0002
739 ROAD TRAFFIC ACCIDENT 8 0.0002
740 JOINT STIFFNESS 5 0.0002
741 MOUTH ULCERATION 4 0.0002
742 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
743 CEREBROVASCULAR ACCIDENT 32 0.0002
744 THROMBOCYTOPENIA 21 0.0002
745 SURGERY 11 0.0002
746 DRY SKIN 25 0.0002
747 DIZZINESS 93 0.0002
748 FEAR 5 0.0002
749 PAIN OF SKIN 5 0.0002
750 RHINORRHOEA 12 0.0002
751 WHEEZING 11 0.0002
752 MUSCLE TIGHTNESS 3 0.0002
753 UNEVALUABLE EVENT 14 0.0002
754 THROAT TIGHTNESS 5 0.0002
755 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
756 SLEEP DISORDER 13 0.0002
757 BIPOLAR DISORDER 2 0.0002
758 SOMNOLENCE 37 0.0002
759 DIABETES MELLITUS 14 0.0002
760 PRODUCT PRESCRIBING ISSUE 4 0.0002
761 MYALGIA 31 0.0002
762 SKIN LESION 5 0.0002
763 CARDIAC ARREST 15 0.0002
764 VENTRICULAR TACHYCARDIA 3 0.0002
765 PHOTOSENSITIVITY REACTION 3 0.0002
766 DENTAL CARIES 2 0.0002
767 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
768 DISCOMFORT 11 0.0002
769 LEUKOPENIA 9 0.0002
770 STEVENS-JOHNSON SYNDROME 4 0.0002
771 SYNCOPE 18 0.0002
772 FEELING COLD 5 0.0002
773 INTESTINAL PERFORATION 2 0.0002
774 FACE OEDEMA 3 0.0002
775 HEMIPARESIS 3 0.0002
776 PAIN IN JAW 5 0.0002
777 IMPAIRED DRIVING ABILITY 2 0.0002
778 CHOLECYSTECTOMY 2 0.0002
779 VISION BLURRED 24 0.0002
780 ANGINA PECTORIS 5 0.0002
781 SKIN DISCOLOURATION 8 0.0002
782 HERPES ZOSTER 10 0.0002
783 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
784 EXTRA DOSE ADMINISTERED 7 0.0002
785 DYSKINESIA 7 0.0002
786 HAEMORRHAGE 18 0.0002
787 BLOOD CHOLESTEROL INCREASED 8 0.0002
788 DEVICE USE ISSUE 3 0.0002
789 PRODUCT USE ISSUE 32 0.0002
790 DEPRESSED MOOD 9 0.0002
791 GALLBLADDER DISORDER 3 0.0002
792 CONDITION AGGRAVATED 51 0.0002
793 MIGRAINE 16 0.0002
794 HYPERLIPIDAEMIA 2 0.0002
795 DEVICE ISSUE 15 0.0002
796 FLUSHING 17 0.0002
797 ADVERSE DRUG REACTION 15 0.0002
798 OSTEOMYELITIS 3 0.0002
799 ARTHRITIS 13 0.0002
800 CRYING 6 0.0002
801 RENAL FAILURE ACUTE 7 0.0002
802 BLOOD GLUCOSE INCREASED 31 0.0002
803 NEURALGIA 4 0.0002
804 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
805 GENERALISED OEDEMA 2 0.0002
806 HEPATIC STEATOSIS 3 0.0002
807 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
808 HEPATIC CIRRHOSIS 3 0.0002
809 PARAESTHESIA 25 0.0002
810 HYPOCALCAEMIA 3 0.0002
811 GASTRIC ULCER 3 0.0002
812 HAEMATEMESIS 4 0.0002
813 DRUG INTERACTION 25 0.0002
814 FEELING JITTERY 3 0.0002
815 EMOTIONAL DISTRESS 19 0.0002
816 GLAUCOMA 3 0.0002
817 MOVEMENT DISORDER 5 0.0002
818 NIGHT SWEATS 5 0.0002
819 ANAPHYLACTIC SHOCK 4 0.0002
820 ERUCTATION 3 0.0002
821 PRESCRIBED OVERDOSE 3 0.0002
822 DYSTONIA 3 0.0002
823 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
824 SKIN EXFOLIATION 13 0.0002
825 PALPITATIONS 18 0.0002
826 PRURITUS 59 0.0002
827 SKIN FISSURES 3 0.0002
828 SEDATION 4 0.0002
829 OSTEONECROSIS 5 0.0002
830 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
831 ABNORMAL BEHAVIOUR 6 0.0002
832 HEART RATE INCREASED 15 0.0002
833 ADVERSE REACTION 2 0.0002
834 EYE HAEMORRHAGE 2 0.0001
835 NEOPLASM MALIGNANT 10 0.0001
836 IRRITABILITY 9 0.0001
837 SWELLING 14 0.0001
838 CYTOKINE RELEASE SYNDROME 3 0.0001
839 PRODUCT USE IN UNAPPROVED INDICATION 37 0.0001
840 JOINT RANGE OF MOTION DECREASED 2 0.0001
841 EYE PRURITUS 5 0.0001
842 PRODUCT PHYSICAL ISSUE 3 0.0001
843 TYPE 2 DIABETES MELLITUS 5 0.0001
844 BLOOD BILIRUBIN INCREASED 4 0.0001
845 FREQUENT BOWEL MOVEMENTS 4 0.0001
846 BONE MARROW FAILURE 3 0.0001
847 DRUG TOXICITY 2 0.0001
848 HEPATIC ENZYME INCREASED 10 0.0001
849 CORONARY ARTERY OCCLUSION 2 0.0001
850 RESPIRATORY ARREST 4 0.0001
851 HAEMATOCHEZIA 8 0.0001
852 ABNORMAL DREAMS 4 0.0001
853 HYPOGLYCAEMIA 7 0.0001
854 CARDIO-RESPIRATORY ARREST 6 0.0001
855 COORDINATION ABNORMAL 2 0.0001
856 WITHDRAWAL SYNDROME 6 0.0001
857 HYPERKALAEMIA 5 0.0001
858 HEART RATE DECREASED 5 0.0001
859 TOXICITY TO VARIOUS AGENTS 24 0.0001
860 SUICIDAL IDEATION 13 0.0001
861 LIVER FUNCTION TEST INCREASED 3 0.0001
862 HYPOACUSIS 6 0.0001
863 SKIN CANCER 3 0.0001
864 ACCIDENTAL UNDERDOSE 2 0.0001
865 DEVICE LEAKAGE 6 0.0001
866 ANOSMIA 2 0.0001
867 ALOPECIA 27 0.0001
868 APATHY 2 0.0001
869 GASTROENTERITIS 2 0.0001
870 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
871 MUSCULOSKELETAL STIFFNESS 12 0.0001
872 PSYCHOTIC DISORDER 4 0.0001
873 CARDIOMYOPATHY 2 0.0001
874 LIVER DISORDER 6 0.0001
875 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
876 RENAL INJURY 4 0.0001
877 IMMUNODEFICIENCY 2 0.0001
878 INFLUENZA LIKE ILLNESS 11 0.0001
879 HYPOAESTHESIA ORAL 2 0.0001
880 CORONARY ARTERY DISEASE 4 0.0001
881 RENAL IMPAIRMENT 11 0.0001
882 DRUG DISPENSING ERROR 2 0.0001
883 TINNITUS 6 0.0001
884 DEVICE ADHESION ISSUE 2 0.0001
885 OFF LABEL USE 114 0.0001
886 PERICARDIAL EFFUSION 3 0.0001
887 BURNING SENSATION 9 0.0001
888 BONE DENSITY DECREASED 4 0.0001
889 ANAPHYLACTIC REACTION 7 0.0001
890 MOOD SWINGS 4 0.0001
891 HYPOTHYROIDISM 4 0.0001
892 METABOLIC ACIDOSIS 4 0.0001
893 HYPONATRAEMIA 7 0.0001
894 HYPERSENSITIVITY 23 0.0001
895 MENTAL IMPAIRMENT 3 0.0001
896 UNDERDOSE 9 0.0001
897 SWELLING FACE 8 0.0001
898 BLINDNESS 5 0.0001
899 AGITATION 9 0.0001
900 EYE IRRITATION 7 0.0001
901 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
902 VISUAL ACUITY REDUCED 4 0.0001
903 CYTOMEGALOVIRUS INFECTION 2 0.0001
904 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
905 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
906 INFLAMMATION 6 0.0001
907 EXPOSURE VIA SKIN CONTACT 3 0.0001
908 ASTHMA 13 0.0001
909 DRUG DOSE OMISSION 19 0.0001
910 ECZEMA 6 0.0001
911 PANCREATITIS 6 0.0001
912 BRADYCARDIA 6 0.0001
913 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
914 JAUNDICE 3 0.0001
915 DISTURBANCE IN ATTENTION 6 0.0001
916 PANIC ATTACK 4 0.0001
917 TREATMENT NONCOMPLIANCE 6 0.0001
918 SKIN IRRITATION 5 0.0001
919 AMNESIA 7 0.0001
920 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
921 TARDIVE DYSKINESIA 3 0.0001
922 INFUSION RELATED REACTION 7 0.0001
923 OCULAR HYPERAEMIA 5 0.0001
924 COMA 5 0.0001
925 VISUAL IMPAIRMENT 13 0.0001
926 MULTIPLE SCLEROSIS 5 0.0001
927 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
928 MYOCARDIAL INFARCTION 18 0.0001
929 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
930 CHOKING 2 0.0001
931 TACHYCARDIA 9 0.0001
932 INJURY 7 0.0001
933 HEPATIC FAILURE 3 0.0001
934 INTENTIONAL SELF-INJURY 2 0.0001
935 DEVICE BREAKAGE 4 0.0001
936 VERTIGO 6 0.0001
937 LUNG NEOPLASM MALIGNANT 4 0.0001
938 FEMUR FRACTURE 3 0.0001
939 NERVOUSNESS 5 0.0001
940 IMPAIRED WORK ABILITY 2 0.0001
941 DRUG EFFECT DECREASED 5 0.0001
942 ACNE 7 0.0001
943 VAGINAL HAEMORRHAGE 4 0.0001
944 EXPIRED PRODUCT ADMINISTERED 3 0.0001
945 RHEUMATOID ARTHRITIS 10 0.0001
946 ERYTHEMA 18 0.0001
947 GASTRIC DISORDER 3 0.0001
948 ADVERSE EVENT 8 0.0001
949 NIGHTMARE 3 0.0001
950 DEVICE USE ERROR 3 0.0001
951 DIABETIC KETOACIDOSIS 2 0.0001
952 ILL-DEFINED DISORDER 5 0.0001
953 ACCIDENTAL OVERDOSE 3 0.0001
954 HEPATIC FUNCTION ABNORMAL 3 0.0001
955 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
956 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
957 CARDIOVASCULAR DISORDER 2 0.0001
958 DEAFNESS 2 0.0001
959 INCORRECT DOSE ADMINISTERED 17 0.0001
960 URTICARIA 12 0.0001
961 INTENTIONAL DOSE OMISSION 2 0.0001
962 PRODUCT SUBSTITUTION ISSUE 4 0.0001
963 ANGIOEDEMA 3 0.0001
964 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
965 THERAPEUTIC RESPONSE DECREASED 4 0.0001
966 DRUG ADMINISTRATION ERROR 2 0.0001
967 EMOTIONAL DISORDER 2 0.0001
968 ARRHYTHMIA 3 0.0001
969 LACTIC ACIDOSIS 2 0.0001
970 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
971 C-REACTIVE PROTEIN INCREASED 2 0.0001
972 CONVULSION 3 0.0001
973 DRUG INEFFECTIVE 69 0.0001
974 INJECTION SITE HAEMORRHAGE 4 0.0001
975 OVERDOSE 10 0.0000
976 INJECTION SITE PRURITUS 3 0.0000
977 PRODUCT QUALITY ISSUE 6 0.0000
978 BREAST CANCER 4 0.0000
979 DEVICE MALFUNCTION 3 0.0000
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
981 DISEASE RECURRENCE 2 0.0000
982 INJECTION SITE PAIN 12 0.0000
983 PROSTATE CANCER 3 0.0000
984 DRUG ABUSE 3 0.0000
985 INTENTIONAL OVERDOSE 2 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 INJECTION SITE REACTION 2 0.0000
988 INJECTION SITE BRUISING 2 0.0000
989 PSORIASIS 3 0.0000
990 INTENTIONAL PRODUCT MISUSE 2 0.0000
991 DRUG DEPENDENCE 3 0.0000
992 NO ADVERSE EVENT 3 0.0000
993 INJECTION SITE ERYTHEMA 2 0.0000